Sven Eisold
Impact in
-
- Pancreatic and Hepatic Oncology Research
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cancer-related Molecular Pathways
-
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
Papers in
- Oncology 9
- Pancreatic and Hepatic Oncology Research 5
- Cancer Immunotherapy and Biomarkers 2
- Drug Transport and Resistance Mechanisms 2
-
- Immunotherapy and Immune Responses 7
- Co-authors
- Jan Schmidt (7 shared papers)Markus W. B�chler (1 shared paper)Michael Linnebacher (9 shared papers)Eduard Ryschich (5 shared papers)Guido Alsfasser (2 shared papers)Magnus von Knebel Doeberitz (5 shared papers)Frank Autschbach (1 shared paper)M W Büchler (1 shared paper)
- Journals
- International Journal of Cancer (2 papers)Surgery (1 paper)International Journal of Oncology (1 paper)Cancer Gene Therapy (1 paper)Pancreatology (1 paper)
- Partner nations
- Germany
In The Last Decade
Sven Eisold
23 papers receiving 344 citations
Peers
Comparison fields: 5 of 42
- Oncology 176
- Immunology 55
- Epidemiology 63
- Genetics 36
- Biotechnology 8
Countries citing papers authored by Sven Eisold
This map shows the geographic impact of Sven Eisold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sven Eisold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sven Eisold more than expected).
Fields of papers citing papers by Sven Eisold
This network shows the impact of papers produced by Sven Eisold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sven Eisold. The network helps show where Sven Eisold may publish in the future.
Co-authors
The 25 scholars most cited alongside Sven Eisold, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 73 | |
| 2 | 2004 | 38 | |
| 3 | 2018 | 33 | |
| 4 | 2003 | 28 | |
| 5 | 2004 | 26 | |
| 6 | 2012 | 26 | |
| 7 | 2000 | 21 | |
| 8 | 2018 | 21 | |
| 9 | 2002 | 14 | |
| 10 | 2006 | 11 | |
| 11 | 2008 | 9 | |
| 12 | 2004 | 8 | |
| 13 | 2009 | 8 | |
| 14 | 2007 | 7 | |
| 15 | 2000 | 6 | |
| 16 | 2011 | 6 | |
| 17 | 2009 | 4 | |
| 18 | 2014 | 4 | |
| 19 | 2002 | 3 | |
| 20 | 1996 | 2 |
About Sven Eisold
Sven Eisold is a scholar working on Oncology, Immunology, Genetics, Epidemiology and Emergency Medical Services, having authored 23 papers that have together received 353 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (7 papers), Pancreatic and Hepatic Oncology Research (5 papers), Virus-based gene therapy research (4 papers), Neuroendocrine Tumor Research Advances (3 papers), Cancer Immunotherapy and Biomarkers (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Central Venous Catheters and Hemodialysis (1 paper) and Aortic aneurysm repair treatments (1 paper). The work is most often cited by research in Oncology (176 citations), Immunology (55 citations), Epidemiology (63 citations), Genetics (36 citations) and Biotechnology (8 citations). Sven Eisold has collaborated with scholars based in Germany. Frequent co-authors include Jan Schmidt, Markus W. B�chler, Michael Linnebacher, Eduard Ryschich, Guido Alsfasser, Magnus von Knebel Doeberitz, Frank Autschbach, M W Büchler, Margot Zöller and Johannes F. Gebert. Their work appears in journals such as International Journal of Cancer, Surgery, International Journal of Oncology, Cancer Gene Therapy and Pancreatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.